Hi everyone, i got confused at the concept "transcripts" and "isoforms", in some paper they mentioned "transcripts", some paper mentioned "isoforms", some mentioned both, i thought they were the same, is that right? Sorry for this silly questions. Thank you very much!
-
-
An isoform is a specific splice variant of an expressed gene. I'd say that a transcript is too, but I think the word "transcript" tends to be used a lot more loosely than "isoform". -
An isoform is specifically one of many splice variants of a gene, while a transcript is an expressed sequence. The difference is that "isoform" implies that there are multiple isoforms, while transcript makes no such implication. For example, prokaryote genes are mostly not spliced, so referring to them as isoforms generally does not make sense. For eukaryote genes with conditionally-used exons, referring to the individual expressed sequences as isoforms is useful.Comment
-
"The difference is that "isoform" implies that there are multiple isoforms, while transcript makes no such implication"
Hi Brian, As you mentioned, i think isoform means there are alternative splicing, is that right? and for transcript can i suppose the expressed transcript is an expressed gene if this transcript has no isoform?Comment
-
It depends on your source and the paper you are reading, but I don't think you can assume that something referred to as a "transcript" has no alternative isoforms (unless it's a prokaryote). On the other hand, you can assume that something referred to as an isoform does have alternative isoforms.Originally posted by crayfish View Post
That said, some bioinformatics pipelines (eg trinity) will automatically pick both "genes" and "isoforms" and in this case, the program can refer to something as an "isoform" even if it has only picked one "isoform".Last edited by danwiththeplan; 04-29-2014, 08:47 PM.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment